BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28914795)

  • 1. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
    Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor.
    Gollapalli M; Taha M; Javid MT; Almandil NB; Rahim F; Wadood A; Mosaddik A; Ibrahim M; Alqahtani MA; Bamarouf YA
    Bioorg Chem; 2019 Apr; 85():33-48. PubMed ID: 30599411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li X; Li J
    Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies.
    Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N
    Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors.
    Xie Z; Wang G; Wang J; Chen M; Peng Y; Li L; Deng B; Chen S; Li W
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28425975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies.
    Taha M; Ismail NH; Lalani S; Fatmi MQ; Atia-Tul-Wahab ; Siddiqui S; Khan KM; Imran S; Choudhary MI
    Eur J Med Chem; 2015 Mar; 92():387-400. PubMed ID: 25585009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
    Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
    Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
    Wang G; Chen M; Qiu J; Xie Z; Cao A
    Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry as α-glucosidase inhibitors.
    Wang G; Peng Z; Wang J; Li J; Li X
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5719-5723. PubMed ID: 27810241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.
    Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F
    Bioorg Chem; 2017 Feb; 70():184-191. PubMed ID: 28043716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management.
    Ullah S; Mirza S; Salar U; Hussain S; Javaid K; Khan KM; Khalil R; Atia-Tul-Wahab ; Ul-Haq Z; Perveen S; Choudhary MI
    Med Chem; 2020; 16(6):826-840. PubMed ID: 31195949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
    Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
    Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.
    Rahim F; Ullah H; Javid MT; Wadood A; Taha M; Ashraf M; Shaukat A; Junaid M; Hussain S; Rehman W; Mehmood R; Sajid M; Khan MN; Khan KM
    Bioorg Chem; 2015 Oct; 62():15-21. PubMed ID: 26162519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
    Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
    Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
    Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.